March 7 (Reuters) - Imugene Ltd (IMU) :
- Manufacturing update
- Updates on manufacturing of its her-vaxx cancer immunotherapy product, currently initiating activity in gastric cancer
- Entire process of her-vaxx cancer immunotherapy product development has resulted in saving of > $500,000 to imugene's bottom line from original budget
News: IMU Imugene Ltd updates on cancer immunotherapy product development
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.040(13.3%) |
Mkt cap ! $100.5M | |||
| Open | High | Low | Value | Volume |
| 29.5¢ | 34.0¢ | 29.5¢ | $2.248M | 6.980M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 26856 | 33.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 37329 | 2 |
View Market Depth
| Last trade - 16.10pm 16/09/2025 (20 minute delay) ? |
| IMU (ASX) Chart |